Evidence map›Paper›PMID 32786044›Full record

GuidelineCancer2020

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.

Sharon Elad, Karis Kin Fong Cheng, Rajesh V Lalla, Noam Yarom, Catherine Hong, Richard M Logan, Joanne Bowen, Rachel Gibson, Deborah P Saunders, Yehuda Zadik and 5 more

Erratum issued 8 registry-linked trialsOpen access · hybridAbstract readPractice GuidelineSystematic Review
In one paragraph

Guideline in Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 8 registered trials, which are not on this map. Cited by 366 papers, 18 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
366citing papers in PubMed, 18 pooled it
64.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04699487 nacompletednot on this mapstarted 2021, after this paper: background citation

Efficacy and Safety of CareMin650 Used for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer Starting Radiotherapy: the PrOMiSE Study

TypeinterventionalSponsorNeoMedLightRan2021 to 2022Enrolled15ConditionsHead and Neck Cancer, Oral Mucositis (Ulcerative) Due to Radiation, Radiation Therapy ComplicationArmsPhotobiomodulation
NCT05211622 phase4unknown statusnot on this mapstarted 2022, after this paper: background citation

OZOCLO: a Randomized Clinical Trial for Prevention of Oral Mucositis

TypeinterventionalSponsorUniversity of PalermoRan2022 to 2023Enrolled80ConditionsMucositis (MeSH Unique ID: D052016), Stomatitis (MeSH Unique ID: D013280)Arms1. alpha acid lipoic - tables, 2. ozonated oil - mouthwash, 3. chlorhexidine 0,2% - mouthwash, 4. sodium bicarbonate 5% solution - mouthwash
NCT05338398 phase1 / phase2unknown statusnot on this mapstarted 2022, after this paper: background citation

A Phase 1/Phase 2 Study for the Prevention of Oral Mucositis (SPOM)

TypeinterventionalSponsorE2Bio Life Sciences, LLCRan2022 to 2023Enrolled100ConditionsOral MucositisArmsBocaliner, Benzydamine
NCT05664906 phase1 / phase2unknown statusnot on this mapstarted 2023, after this paper: background citation

Evaluating Efficacy and Safety of Chinese Medicine Oral Rinse in Treating and Preventing Irradiated Oral Mucositis in Head-and-Neck Cancer Patients - a Pilot Trial

TypeinterventionalSponsorChinese University of Hong KongRan2023 to 2024Enrolled40ConditionsHead and Neck Neoplasms, Oral Mucositis (Ulcerative) Due to Radiation, Chinese Medicine Oral RinseArmsChinese Medicine Oral Rinse Formula-I (CMORF-I), Standard Care, Placebo
NCT06071637 phase3recruitingnot on this mapstarted 2023, after this paper: background citation

Low Power Laser Therapy As Prevention Of Oral Mucositis And Oropharyngeal Pain In Patients Undergoing Allogenetic Hematopoietic Stem Cell Transplantation.

TypeinterventionalSponsorInstituto Nacional de Cancer, BrazilRan2023 to 2027Enrolled84ConditionsHematopoietic Stem Cell Transplantation, Low-Level Light Therapy, StomatitisArmsDouble low-power laser therapy simultaneous applicated
NCT06260111 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Laser Photobiomodulation to Prevent Oral Mucositis and Functional Impairment Among Adult Hematologic Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation

TypeinterventionalSponsorUniversidad del DesarrolloRan2024 to 2025Enrolled30ConditionsHematologic CancerArmsPhotobiomodulation, Usual care
NCT07387978 narecruitingnot on this mapstarted 2025, after this paper: background citation

A Pilot Study to Describe the Effect of Photobiomodulation in Reducing the Severity and Incidence of Oral Mucositis in Oral Cancer Patients Undergoing Radiation Treatment

TypeinterventionalSponsorPeter MacCallum Cancer Centre, AustraliaRan2025 to 2028Enrolled30ConditionsOral MucositisArmsphotobiomodulation
NCT07605234 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Phase II Single Arm Study of Photobiomodulation as an Adjunct to Standard Supportive Care for Chemotherapy Induced Oral Mucositis in Pediatric Patients

TypeinterventionalSponsorTata Memorial HospitalRan2026 to 2027Enrolled46ConditionsOral Mucositis Due to Chemotherapy, Hematolymphoid MalignanciesArmsPhotobiomodulation Therapy
3 · Its place in the literature

Who cites it

366 citing papers in PubMed, 18 syntheses or guidelines pooled it, 1,229 citations in OpenAlex.

  1. Pooled it
  2. Photobiomodulation for oral mucositis in cancer care: prevention, clinical management, and evidence from randomized controlled trials.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Pooled it
  3. Guideline
  4. Pooled it
  5. Systematic review of prophylactic antibacterial agents for radiation-induced oral mucositis in head and neck cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Guideline
  13. Guideline
  14. Risk factors for chemotherapy-induced oral mucositis in cancer patients: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Pooled it
  15. Guideline
  16. Pooled it
  17. Pooled it
  18. Pooled it
  19. N-acetylcysteine mouthwash for prevention of oral mucositis in hematopoietic cell transplant recipients: a double-blind randomized controlled trial.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Trial
  20. Effectiveness of oral cryotherapy in preventing methotrexate-induced oral mucositis in pediatric patients with acute lymphoblastic leukemia: a randomized controlled trial.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Trial

306 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 11 institutions in 7 countries.

Sharon EladEastman Institute for Oral Health, University of Rochester Medical Center, Rochester, New York.
Karis Kin Fong ChengYong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Rajesh V LallaUniversity of Connecticut School of Dental Medicine, UConn Health, Farmington, Connecticut.
Noam YaromSheba Medical Center, Tel Hashomer, and Tel Aviv University, Tel Aviv, Israel.
Catherine HongFaculty of Dentistry, National University of Singapore, Singapore, Singapore.
Richard M LoganAdelaide Dental School, University of Adelaide, Adelaide, South Australia, Australia.
Joanne BowenAdelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.
Rachel GibsonSchool of Allied Health Science and Practice, University of Adelaide, Adelaide, South Australia, Australia.
Deborah P SaundersNorth East Cancer Center, Health Sciences North, Northern Ontario School of Medicine, Sudbury, Ontario, Canada.
Yehuda ZadikFaculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.ORCID 0000-0002-6062-6529
Anura AriyawardanaCollege of Medicine and Dentistry, James Cook University, Cairns, Queensland, Australia.
Maria Elvira CorreaSchool of Medical Science, University of Campinas-Cidade, Zeferino Vaz University, Barao Geraldo, Brazil.
Vinisha RannaThe Mount Sinai Hospital, New York, New York.
Paolo BossiMedical Oncology Department, University of Brescia, Brescia, Italy.
Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO)
The University of Adelaide · AUNational University of Singapore · SGHealth Sciences North · CAHebrew University of Jerusalem · ILJames Cook University · AUMount Sinai Hospital · USTel Aviv University · ILUConn Health · USUniversidade Estadual de Campinas (UNICAMP) · BRUniversity of Brescia · ITUniversity of Rochester Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMucositis is a significant toxicity of cancer therapy with numerous systemic sequelae. The goal of this systematic review was to update the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) Clinical Practice Guidelines for the management of mucositis.

methodsThe literature was reviewed systematically to identify interventions for mucositis. Studies were rated according to the presence of major and minor flaws according to previously published criteria. The body of evidence for each intervention and in each treatment setting was assigned a level of evidence based on previously published criteria. Guidelines were developed based on the level of evidence, with 3 possible guideline determinations: recommendation, suggestion, or no guideline possible.

resultsThe guideline covers evidence from 1197 publications related to oral or gastrointestinal mucositis. Thirteen new guidelines were developed for or against the use of various interventions in specific treatment settings, and 11 previous guidelines were confirmed after aa review of new evidence. Thirteen previously established guidelines were carried over because there was no new evidence for these interventions.

conclusionsThe updated MASCC/ISOO Clinical Practice Guidelines for mucositis provide professional health caregivers with a clinical setting-specific, evidence-based tool to help with the management of mucositis in patients who have cancer.

Indexed as

HumansMucositisNeoplasmscancergastrointestinalguidelinesmucositisMultinational Association of Supportive Care in Cancer and International Society for Oral Oncology (MASCC/ISOO)oral

Identifiers

PMID32786044
PMCPMC7540329
OpenAlexW2158334747

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

and 2 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.